about
FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and RictorRegulation and function of AMPK in physiology and diseasesUp-regulation of cytoskeletal-associated protein 2 in primary human gastric adenocarcinomas.A cytoskeleton-associated protein, TMAP/CKAP2, is involved in the proliferation of human foreskin fibroblasts.The effect Akt2 deletion on tumor development in Pten(+/-) mice.Antiviral Activity of Oroxylin A against Coxsackievirus B3 Alleviates Virus-Induced Acute Pancreatic Damage in MiceA clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer.AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress.Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms.Cardiac glycosides display selective efficacy for STK11 mutant lung cancer.The double-edged sword of AMPK signaling in cancer and its therapeutic implications.Trans-scirpusin A showed antitumor effects via autophagy activation and apoptosis induction of colorectal cancer cells.Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice.Dysregulation of NRF2 in Cancer: from Molecular Mechanisms to Therapeutic Opportunities.Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin.Antiviral and anti-inflammatory activity of budesonide against human rhinovirus infection mediated via autophagy activation.Exploring vitamin D metabolism and function in cancer.microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer.Expanding the concepts of cancer metabolism.Author Correction: Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin.Association between glucose-lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancyTargeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancerNRF2-driven redox metabolism takes center stage in cancer metabolism from an outside-in perspective
P50
Q24632191-884C7CD2-52C6-4FA8-B08A-E6C966CE35D2Q26740291-FC011D7E-C871-4224-8DDF-89800ABE6877Q34225724-2485D77F-7210-4F6E-B939-17458448F52DQ34552252-74A1E024-29F9-400A-82D1-A0B9C8606D8AQ35738371-5B789B2B-BA56-42CD-93E5-85D0F5C44BF0Q36022033-A6AE2707-E023-497A-AE9D-10C4DDB336CEQ36371799-4ACF8F51-CDE8-4D0C-A75B-114EECD90C98Q36713683-D0339118-D066-4A99-A92B-A11A37D22C64Q37038522-26C74E52-D315-471B-BA11-B89D56B82056Q37105125-C732FF5C-7F8E-48E3-8B37-FA104C6A34E0Q38313164-2350EE88-3E56-4E9E-8139-710D06620D47Q41093636-F07FE25E-0744-446B-B8BB-F8CBEA97BDCBQ41997926-D0DC4EB8-B5D7-4073-9B2D-26DE135EF2BFQ47108372-73588FBD-A1BC-44DB-848B-C6657467D525Q48130799-3EFFB340-B2CB-4CE8-8EBD-9E938E1FD08FQ50175833-ABB60196-5878-4198-B54A-0F9042795FA9Q52587327-AF9AD983-BC63-4D06-8BC5-619247989CFCQ54982268-655E9C2F-2FF1-4FE6-90B7-C84E60E3712BQ55096360-07DD9121-808B-4AFB-A101-10B1BD83DEF0Q55308455-1A7A5363-CC54-496C-B720-1FC361F70769Q57212863-911E3BC0-C807-46B6-96A3-7B298D4B1F45Q64100306-4961D3F8-35B7-446A-8413-10AF81B7E336Q90043404-1BCE658E-7A97-4ACE-9908-E3F5C7DC70E0
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sang-Min Jeon
@ast
Sang-Min Jeon
@en
Sang-Min Jeon
@es
Sang-Min Jeon
@nl
Sang-Min Jeon
@sl
type
label
Sang-Min Jeon
@ast
Sang-Min Jeon
@en
Sang-Min Jeon
@es
Sang-Min Jeon
@nl
Sang-Min Jeon
@sl
prefLabel
Sang-Min Jeon
@ast
Sang-Min Jeon
@en
Sang-Min Jeon
@es
Sang-Min Jeon
@nl
Sang-Min Jeon
@sl
P106
P1153
56187590100
P31
P496
0000-0002-0132-925X